Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Human Genetics01:28

Human Genetics

1.7K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.7K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort.

medRxiv : the preprint server for health sciences·2026
Same author

Turbocharging synaptic transmission: 12 SNAREpins are required for rapid release of reconstituted synaptic vesicles.

Science advances·2026
Same author

Early oligodendrocyte dysfunction signature in Alzheimer's disease: Insights from DNA methylomics and transcriptomics.

Molecular psychiatry·2026
Same author

Novel Variants in PUS7 Associated With Intellectual Disability and Growth Retardation: Expanding the Clinical Spectrum in 13 Patients.

Clinical genetics·2026
Same author

COXFA4L2 upregulation preserves residual cytochrome c oxidase activity in COXFA4-related Leigh-like encephalopathy.

Nature communications·2026
Same author

Clinical prognostic indicators in multiple system atrophy.

Brain : a journal of neurology·2026

Related Experiment Video

Updated: Feb 17, 2026

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.1K

Multiple system atrophy: genetic risks and alpha-synuclein mutations.

Heather T Whittaker1, Yichen Qui2, Conceição Bettencourt1,2

  • 1Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.

F1000Research
|December 12, 2017
PubMed
Summary

Multiple system atrophy (MSA) is a rare neurodegenerative disease with unknown causes. Research on alpha-synuclein mutations is advancing understanding of MSA

Keywords:
MSAmultiple system atrophyneurodegenerative disordersα-synuclein

More Related Videos

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.7K

Related Experiment Videos

Last Updated: Feb 17, 2026

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.1K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

11.4K
Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

22.7K

Area of Science:

  • Neurodegenerative diseases
  • Genetics
  • Molecular biology

Background:

  • Multiple system atrophy (MSA) is a rare neurodegenerative disorder with well-defined clinical and pathological features, but an unknown etiology.
  • Significant advancements in understanding MSA have emerged recently due to international research collaborations and genetic discoveries.
  • Key findings in MSA include alpha-synuclein pathology and glial cytoplasmic inclusions.

Purpose of the Study:

  • To review current research on the etiology of Multiple System Atrophy (MSA).
  • To focus specifically on the role of alpha-synuclein mutations in MSA.
  • To discuss controversies surrounding alpha-synuclein variants and pathology spreading in MSA.

Main Methods:

  • Review of recent genetic and molecular discoveries related to MSA.
  • Analysis of studies on alpha-synuclein mutations and their clinical/pathological manifestations.
  • Examination of literature addressing controversies in MSA research.

Main Results:

  • Alpha-synuclein pathology and glial cytoplasmic inclusions are significant findings in MSA.
  • Certain alpha-synuclein mutations can cause diseases mimicking MSA, suggesting a spectrum of severity.
  • The role of common alpha-synuclein variants and shared pathology spreading mechanisms in MSA remains debated.

Conclusions:

  • Alpha-synuclein mutations are central to understanding MSA, though etiology is not fully elucidated.
  • Further research is needed to resolve controversies regarding alpha-synuclein's role and pathology spread in MSA.
  • International collaboration and genetic research are crucial for advancing MSA knowledge.